These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7799495)

  • 1. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.
    Kattlove H; Liberati A; Keeler E; Brook RH
    JAMA; 1995 Jan; 273(2):142-8. PubMed ID: 7799495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of breast cancer screening in women on dialysis.
    Wong G; Howard K; Chapman JR; Craig JC
    Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The patient burden of screening mammography recall.
    Alcusky M; Philpotts L; Bonafede M; Clarke J; Skoufalos A
    J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S11-9. PubMed ID: 25247382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health economics analysis of breast cancer screening].
    Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
    Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
    Olivotto IA; Kan L; Mates D; King S
    CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years.
    Ohnuki K; Kuriyama S; Shoji N; Nishino Y; Tsuji I; Ohuchi N
    Cancer Sci; 2006 Nov; 97(11):1242-7. PubMed ID: 16918992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-benefit analysis of a mammography screening program extended to all the national territory].
    Vanara F; Zappa M; Rosselli del Turco M; Segnan N; Paci E; Ponti A
    Epidemiol Prev; 1997; 21(2):118-28. PubMed ID: 9378179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening: prospects and opportunity costs.
    Navarro AM; Kaplan RM
    Womens Health; 1996; 2(4):209-33. PubMed ID: 9421557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will early detection of breast cancer reduce the costs of treatment?
    Salkeld G; Gerard K
    Aust J Public Health; 1994 Dec; 18(4):388-93. PubMed ID: 7718652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
    Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
    JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
    Temple LK; Wang EE; McLeod RS
    CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
    Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
    Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding patient options, utilization patterns, and burdens associated with breast cancer screening.
    Harvey SC; Vegesna A; Mass S; Clarke J; Skoufalos A
    J Womens Health (Larchmt); 2014 Sep; 23 Suppl 1():S3-9. PubMed ID: 25247383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of breast cancer and the cost-effectiveness of breast cancer screening.
    Elixhauser A
    Int J Technol Assess Health Care; 1991; 7(4):604-15. PubMed ID: 1778705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why question screening mammography for women in their forties?
    Fletcher SW
    Radiol Clin North Am; 1995 Nov; 33(6):1259-71. PubMed ID: 7480669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. United States Preventive Services Task Force screening mammography recommendations: science ignored.
    Hendrick RE; Helvie MA
    AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.